Article Tools

U.S. Forest Laboratories Cooperates with Nabriva

Published: June 2, 2012; 12:37 · (Vindobona)

The U.S. pharmaceutical company provides funds of $ 25m to the Austrian Nabriva and secures pre-emptory rights.

U.S. Forest Laboratories Cooperates with Nabriva / Picture: © Flickr

Forest Laboratories and Nabriva Therapeutics announced today they have entered into an agreement for the development of Nabriva’s novel antibacterial agent, BC-3781.  Pursuant to the agreement, Forest will provide Nabriva with $ 25m, and fund and conduct in collaboration with Nabriva, certain development activities related to BC-3781 over the next 12 months.  During the 12-month…

This article includes a total of 472 words.

or Log In